GUTS
Fractyl Health, Inc. Common Stock
NASDAQ: GUTS · HEALTHCARE · BIOTECHNOLOGY
$0.64
+5.90% today
Updated 2026-04-30
Market cap
$103.61M
P/E ratio
—
P/S ratio
7,575.74x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$0 – $3
Volume
2.3M
Fractyl Health, Inc. Common Stock (GUTS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $8.93M | $34.76M | $102.55M | $60.96M | $76.21M | $108.08M |
| Cash & equivalents | $5.79M | $29.11M | $95.47M | $49.27M | $33.21M | $67.46M |
| Current assets | $6.78M | $30.88M | $96.39M | $51.63M | $35.65M | $71.76M |
| Total liabilities | $152.93M | $19.81M | $311.87M | $313.27M | $401.27M | $79.65M |
| Current liabilities | $3.41M | $10.92M | $23.65M | $7.31M | $11.19M | $19.77M |
| Long-term debt | $14.90M | $8.12M | — | $17.76M | $55.15M | $30.16M |
| Shareholder equity | $-144.00M | $14.95M | $-209.32M | $-252.32M | $-325.06M | $28.42M |
| Retained earnings | $-153.86M | $-184.34M | $-223.07M | $-269.52M | $-346.62M | $-415.31M |
| Accounts receivable | — | — | — | $0.00 | $22000.00 | $22000.00 |
| Inventory | — | — | — | $0.00 | $73000.00 | $73000.00 |
| Goodwill | — | — | — | — | — | — |